IndraLab
Statements
OTUD6B affects Delta-actitoxin-Avd1a
|
610
Delta-actitoxin-Avd1a binds OTUD6B. 10 / 609
|
609
Delta-actitoxin-Avd1a binds OTUD6B and mtf1. 1 / 1
|
1
sparser
"Thus, we link proteolytic ubiquitylation with post‐transcriptional regulation and nominate OTUD6B as a potential mediator of the MGUS‐multiple myeloma transition, a central regulator of MYC, and an actionable vulnerability in multiple myeloma and other tumors with an activated OTUD6B‐LIN28B axis."
sparser
"Strikingly, we found a significant downregulation of prominent MYC targets (Mootha et al , xref ; Subramanian et al , xref ) in OTUD6B and LIN28B depleted MM cells, suggesting a direct impact of the OTUD6B‐LIN28B axis on MYC expression and activity (Fig xref , and Appendix Fig xref A)."
sparser
"In addition, OTUD6B depletion reduced the inhibitory effects of ectopic pVHL missense mutants on cell migration and HIF-2α level, except for pVHL I151T. Thus, we speculated that I151 residue might be one of key sites of pVHL binding to OTUD6B. These results suggested that OTUD6B is an important regulator for the stability of pVHL missense mutants, which provides a potential therapeutic strategy for ccRCC with VHL mutations."
sparser
"At the same time, we observed that OTUD6B depletion reduced the inhibitory effects of pVHL wild-type and the mutants on cell migration and HIF-2α level, except for pVHL 151T mutant (Fig. xref a and b), suggesting that I151 residue might be one of key sites of pVHL binding to OTUD6B."
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
reach
"Moreover, mutant forms of OTUD6B with deletion of OTU domain or mutating the putative catalytic active sites could still suppress the ubiquitination of pVHL, which is consistent with previous report showing that OTUD6B is incapable of cutting any di-ubiquitin in vitro (Mevissen et al., 2013)."
reach
"Hence, these data suggest that as a transcriptional target gene of HIF, OTUD6B expression could be induced under the hypoxic condition to stabilize pVHL and promote the degradation of HIF-1α, thus forming a negative feedback loop in regulating HIF activity and oxygen sensing homeostasis.Taken together, this work reveals a new layer of molecular mechanism for the stability regulation of the pVHL tumor suppressor and reveals its potential clinical importance in HCC metastasis and treatment."
sparser
"Thus, we link proteolytic ubiquitylation with post‐transcriptional regulation and nominate OTUD6B as a potential mediator of the MGUS‐multiple myeloma transition, a central regulator of MYC, and an actionable vulnerability in multiple myeloma and other tumors with an activated OTUD6B‐LIN28B axis."
sparser
"Strikingly, we found a significant downregulation of prominent MYC targets (Mootha et al , xref ; Subramanian et al , xref ) in OTUD6B and LIN28B depleted MM cells, suggesting a direct impact of the OTUD6B‐LIN28B axis on MYC expression and activity (Fig xref , and Appendix Fig xref A)."
sparser
"In addition, OTUD6B depletion reduced the inhibitory effects of ectopic pVHL missense mutants on cell migration and HIF-2α level, except for pVHL I151T. Thus, we speculated that I151 residue might be one of key sites of pVHL binding to OTUD6B. These results suggested that OTUD6B is an important regulator for the stability of pVHL missense mutants, which provides a potential therapeutic strategy for ccRCC with VHL mutations."
sparser
"At the same time, we observed that OTUD6B depletion reduced the inhibitory effects of pVHL wild-type and the mutants on cell migration and HIF-2α level, except for pVHL 151T mutant (Fig. xref a and b), suggesting that I151 residue might be one of key sites of pVHL binding to OTUD6B."
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
reach
"Together, these findings highlight OTUD6B as a DUB that maintains KIFC1 levels to ensure supernumerary centrosomes remain clustered, allowing cancer cells to avoid mitotic catastrophe and complete cell division.Amongst the 94 DUBs screened, we found that depletion of only OTUD6B or JOSD2 could both reduce cellular KIFC1 levels and increase multipolar spindles in TNBC cells (Figs."
reach
"Importantly, OTUD6B depletion could reduce KIFC1 expression in other cancer cell lines: MDA-MB-231, another TNBC cell line with moderate centrosome amplification, U2OS osteosarcoma cells that were originally used to demonstrate KIFC1 ubiquitination by the APC/C (Min et al, 2014), as well as in hTERT-HME1 as a model of immortalised normal breast epithelium (Fig. EV2E–G)."
reach
"Whilst modulating OTUD6B had little effect on KIFC1 stability or ubiquitination in interphase cells (Fig. EV5I,J), acute ubiquitination of KIFC1 during mitosis (Appendix Fig. S7D) was decreased by overexpression of catalytically active OTUD6B (Fig. 6C) and increased by OTUD6B depletion (Fig. 6B) particularly for K11 polyubiquitin (Fig. 6E)."
reach
"This evidence for catalytic activity of OTUD6B towards K11-linked ubiquitin in other contexts is consistent with its ability to reduce mitotic KIFC1 polyubiquitination (Fig. 6) as the APC/C appends K11-linked and branched chains to substrates (Jin et al, 2008; Meyer and Rape, 2014)."
reach
"We speculate that such a mechanism may enable cancer cells to maintain a check on KIFC1 ubiquitylation during anaphase and telophase, to ensure that supernumerary centrosomes remain clustered so that chromosomes are accurately divided into daughter cells.However, we found that OTUD6B depletion could increase KIFC1 polyubiquitination not only at mitotic exit, but also in prometaphase arrested cells (Fig. 6B) when it had the strongest effect on KIFC1 degradation."
OTUD6B affects cell population proliferation
|
14
OTUD6B activates cell population proliferation.
|
11
OTUD6B inhibits cell population proliferation.
|
3
reach
"Ji and colleagues
219
identified a circRNA called Hsa‐circ‐0003764 (circPTPN12) from the circRNA database, discovering its role in suppressing hepatocellular carcinoma progression by interacting with the PDZ domain of PDLIM2, promoting P65 ubiquitination and the assembly of the PDLIM2/OTUD6B complex, thereby highlighting the ESRP1/circPTPN12/PDLIM2/NF‐κB axis as a potential therapeutic target."
sparser
"To investigate the role of circPTPN12 in this context, we conducted immunoprecipitation experiments and observed reduced binding of PDLIM2 and OTUD6B upon circPTPN12 knockdown, whereas overexpression of circPTPN12 resulted in increased binding of PDLIM2 and OTUD6B. We discovered that circPTPN12 serves as a scaffold, facilitating the interaction between PDLIM2 and OTUD6B, promoting PDLIM2 deubiquitination, maintaining its expression, and exerting its anti-cancer function."
reach
"Ji and colleagues
219
identified a circRNA called Hsa‐circ‐0003764 (circPTPN12) from the circRNA database, discovering its role in suppressing hepatocellular carcinoma progression by interacting with the PDZ domain of PDLIM2, promoting P65 ubiquitination and the assembly of the PDLIM2/OTUD6B complex, thereby highlighting the ESRP1/circPTPN12/PDLIM2/NF‐κB axis as a potential therapeutic target."
sparser
"To investigate the role of circPTPN12 in this context, we conducted immunoprecipitation experiments and observed reduced binding of PDLIM2 and OTUD6B upon circPTPN12 knockdown, whereas overexpression of circPTPN12 resulted in increased binding of PDLIM2 and OTUD6B. We discovered that circPTPN12 serves as a scaffold, facilitating the interaction between PDLIM2 and OTUD6B, promoting PDLIM2 deubiquitination, maintaining its expression, and exerting its anti-cancer function."
All-trans-retinoic acid affects OTUD6B
|
8
All-trans-retinoic acid activates OTUD6B.
|
5
All-trans-retinoic acid activates OTUD6B. 5 / 5
|
5
reach
"Since RARα has been reported to repress the translation of specific mRNAs through binding with the untranslated region (UTR) of target mRNA, and this repression can be relieved by ATRA,
18
we tested whether ATRA promoted the translation of OTUD6B by relieving the binding of RARα to the UTR of OTUD6B mRNA."
All-trans-retinoic acid increases the amount of OTUD6B.
|
2
All-trans-retinoic acid inhibits OTUD6B.
|
1
All-trans-retinoic acid inhibits OTUD6B. 1 / 1
|
1
OTUD6B affects apoptotic process
|
1
7
OTUD6B activates apoptotic process.
|
5
OTUD6B inhibits apoptotic process.
|
1
2
reach
"In support of the notion that OTUD6B enhances β‐TrCP protein stability and thus decreases SNAIL protein level, we found a significant positive correlation between OTUD6B and β‐TrCP protein levels in ESCC tissues (Figure 5C) and a negative correlation between OTUD6B and SNAIL protein levels (Figure 5D)."
OTUD6B affects cell migration
|
6
|
5
OTUD6B activates Pulmonary Arterial Hypertension.
|
4
OTUD6B activates Pulmonary Arterial Hypertension. 4 / 4
|
4
reach
"The knock-down effect of siOtud6b#1 is stronger than siOtud6b#2 and siOtud6b#3.To test whether the reduction of Otud6b inhibits PAH development, we targeted Otud6b (siOtud6b, GGGAATGAAGAACGCCGTT) and non-targeted control (siNC) modified anti-siRNA oligonucleotides by trachea infusion for 3 weeks."
OTUD6B inhibits Pulmonary Arterial Hypertension.
|
1
OTUD6B inhibits Pulmonary Arterial Hypertension. 1 / 1
|
1
sparser
"Through luciferase reporter assay and chromatin immunoprecipitation assay, the authors found that HIF-1α binds with the promoter of OTUD6B . Hence, these data suggest that as a transcriptional target gene of HIF, OTUD6B expression could be induced under the hypoxic condition to stabilize pVHL and promote the degradation of HIF-1α, thus forming a negative feedback loop in regulating HIF activity and oxygen sensing homeostasis."
sparser
"Through luciferase reporter assay and chromatin immunoprecipitation assay, the authors found that HIF-1α binds with the promoter of OTUD6B . Hence, these data suggest that as a transcriptional target gene of HIF, OTUD6B expression could be induced under the hypoxic condition to stabilize pVHL and promote the degradation of HIF-1α, thus forming a negative feedback loop in regulating HIF activity and oxygen sensing homeostasis."
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
OTUD6B affects type I interferon production
|
3
OTUD6B affects defense response to virus
|
3
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
OTUD6B affects Neoplasm Invasiveness
|
3
OTUD6B affects Multiple Myeloma
|
3
OTUD6B activates Multiple Myeloma.
|
2
OTUD6B inhibits Multiple Myeloma.
|
1
OTUD6B inhibits Multiple Myeloma. 1 / 1
|
1
OTUD6B affects LUAD
|
3
OTUD6B affects Interferon
|
3
OTUD6B inhibits Interferon.
|
2
OTUD6B activates Interferon.
|
1
OTUD6B activates Interferon. 1 / 1
|
1
OTUD6B affects Intellectual Disability
|
3
OTUD6B activates Intellectual Disability. 2 / 2
|
2
reach
"Biallelic mutations in the OTUD6B (Ovarian tumor domain-containing 6B) gene were recently described to cause an intellectual disability syndrome characterized by seizures and dysmorphic features in six families worldwide (Santiago-Sim et al., 2017; Online Mendelian Inheritance in Men, OMIM, #617452)."
Mutated OTUD6B activates Intellectual Disability. 1 / 1
|
1
reach
"Compared with hypoxia group, hypoxia + Calpain-1 knockout group not only improved the pathological changes of PAH, but also significantly reduced the protein expression of Otud6b, suggesting that Calpain-1 plays an important role in the regulation of Otud6b.Calpain is a conservative family of calcium dependent cysteine proteases that are commonly expressed in all cells [16, 17]."
Retinoic acid affects OTUD6B
|
2
CircPTPN12 affects OTUD6B
|
2
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
OTUD6B affects viral process
|
2
OTUD6B inhibits viral process.
|
1
OTUD6B inhibits viral process. 1 / 1
|
1
OTUD6B activates viral process.
|
1
OTUD6B activates viral process. 1 / 1
|
1
OTUD6B affects spindle assembly
|
2
OTUD6B affects pathway
|
2
OTUD6B affects immune response
|
2
OTUD6B affects circPTPN12
|
2
OTUD6B affects cell cycle phase transition
|
2
OTUD6B affects acetohydroxamic acid
|
2
sparser
"We used gel filtration chromatography assay to analyze the CBC VHL complex binding of OTUD6B. As shown in Figure xref and Figure S5F (Supporting Information), OTUD6B was detected in the same fractions with pVHL, elongin B, and elongin C, indicating that OTUD6B might be a component of CBC VHL complex."
|
2
reach
"Biallelic mutations in the OTUD6B (Ovarian tumor domain-containing 6B) gene were recently described to cause an intellectual disability syndrome characterized by seizures and dysmorphic features in six families worldwide (Santiago-Sim et al., 2017; Online Mendelian Inheritance in Men, OMIM, #617452)."
OTUD6B affects PAH mice
|
2
OTUD6B affects Neoplasm Metastasis
|
2
OTUD6B inhibits Neoplasm Metastasis. 2 / 2
|
2
reach
"Although this study did not specifically examine whether the activation of HIF itself through hypoxia is regulated by Otud6b, we found that activation of Otud6b expression with rOtud6b does increase HIF expression, which further regulates the transcription of cytokines and important proteins (such as VEGF, ET-1, etc.), which contribute to the development of PAH.We further discussed the regulatory relationship between Otud6b and HIF-1α."
OTUD6B affects Fig. 5F-G
|
2
OTUD6B affects Carcinoma, Renal Cell
|
2
OTUD6B affects Adenocarcinoma of Lung
|
2
OTUD6B activates Adenocarcinoma of Lung. 2 / 2
|
2
Calpain-1 inhibitor affects OTUD6B
|
2
PVHL affects OTUD6B
|
1
Omacetaxine mepesuccinate affects OTUD6B
|
1
Omacetaxine mepesuccinate activates OTUD6B. 1 / 1
|
1
Mtf1 affects OTUD6B
|
1
Delta-actitoxin-Avd1a binds OTUD6B and mtf1. 1 / 1
|
1
Bortezomib affects OTUD6B
|
1
Bortezomib inhibits OTUD6B. 1 / 1
|
1
reach
"By contrast, we speculate that OTUD6B inhibition outweighs the net effect of bortezomib treatment on LIN28B under clinically achievable bortezomib levels and that this effect adds to the general proteotoxic stress induced by bortezomib in order to explain the observed synergy of OTUD6B inhibition and proteasomal inhibition.Unbiased screening identified OTUD6B as a vulnerability in MM."
ROtud6b affects OTUD6B
|
1
OTUD6B affects β‐TrCP protein
|
1
OTUD6B affects viral RNA genome replication
|
1
OTUD6B inhibits viral RNA genome replication. 1 / 1
|
1
OTUD6B affects ubiquitination pVHL
|
1
eidos
"More interestingly , OTU deubiquitinase 6B ( OTUD6B ) as the first reported deubiquitination enzyme is capable of inhibiting pVHL ubiquitination , and the deubiquitination regulation of OTUD6B on pVHL did not depend on its enzyme activity , but via interaction with pVHL to enhance the stability of CBCVHL ubiquitin ligase complex , and reduce the ubiquitination degradation of pVHL by Trp-Asp repeat and suppressors of cytokine signaling box-containing protein 1 ( WSB1 ) and E2-EPF ubiquitin carrier protein ( UCP ) ."
OTUD6B affects ubiquitin E3
|
1
OTUD6B affects tube formation
|
1
OTUD6B activates tube formation. 1 / 1
|
1
OTUD6B affects translation
|
1
OTUD6B activates translation. 1 / 1
|
1
OTUD6B affects traf6-mediated K63-linked polyubiquitination irf3 irf7
|
1
OTUD6B affects tbk1 bind irf3 irf7 resulting irf3 irf7 phosphorylation
|
1
OTUD6B affects signal transduction
|
1
OTUD6B activates signal transduction. 1 / 1
|
1
OTUD6B affects proteasome complex disassembly
|
1
OTUD6B bound to VHL inhibits proteasome complex disassembly. 1 / 1
|
1
OTUD6B affects phosphorylation IRFs molecules
|
1
OTUD6B affects pVHL
|
1
OTUD6B affects mtf1
|
1
Delta-actitoxin-Avd1a binds OTUD6B and mtf1. 1 / 1
|
1
OTUD6B affects mitotic cell cycle
|
1
OTUD6B activates mitotic cell cycle. 1 / 1
|
1
OTUD6B affects miRNA processing
|
1
OTUD6B activates miRNA processing. 1 / 1
|
1
OTUD6B affects inflammatory response
|
1
OTUD6B activates inflammatory response. 1 / 1
|
1
OTUD6B affects growth
|
1
sparser
"When TgMMTV-neu mice (n=5/group) were vaccinated with the individual antigens, vaccination with Pdhx inhibited tumor growth by 62.1%, Otud6B inhibited tumor growth by 23.5%, and Stk39 inhibited tumor growth by 50.3% as compared to empty vector vaccinated control at 27 weeks (p<0.001 for each individual antigen as compared to empty vector)."
| PMC
OTUD6B affects dissociation Cullin 2VHL complex pVHL known upstream E3 ligases
|
1
OTUD6B affects cells migration
|
1
OTUD6B affects cell renal cell carcinoma
|
1
OTUD6B affects cell cycle
|
1
OTUD6B activates cell cycle. 1 / 1
|
1
OTUD6B affects binding TBK1 IRF3 IRF7
|
1
OTUD6B affects beta-TrCP Protein Stability
|
1
OTUD6B affects angiogenesis
|
1
OTUD6B inhibits angiogenesis. 1 / 1
|
1
OTUD6B affects TRAF6-induced K63-linked polyubiquitination IRF3 IRF7
|
1
OTUD6B affects Survival Rate
|
1
OTUD6B inhibits Survival Rate. 1 / 1
|
1
OTUD6B affects RNA, Long Noncoding
|
1
OTUD6B inhibits RNA, Long Noncoding. 1 / 1
|
1
OTUD6B affects Plaque, Atherosclerotic
|
1
OTUD6B inhibits Plaque, Atherosclerotic. 1 / 1
|
1
OTUD6B affects LSCC
|
1
OTUD6B affects K63
|
1
OTUD6B affects K11-
|
1
OTUD6B affects Infections
|
1
OTUD6B inhibits Infections. 1 / 1
|
1
OTUD6B affects IFN-1 activation K63-linked polyubiquitination irf3 irf7
|
1
OTUD6B affects IDDFSDA
|
1
OTUD6B affects Hypertension
|
1
OTUD6B activates Hypertension. 1 / 1
|
1
OTUD6B affects HUVEC
|
1
OTUD6B affects First Spanish case
|
1
OTUD6B affects EV4A
|
1
OTUD6B affects Delta-actitoxin-Avd1c
|
1
Delta-actitoxin-Avd1c binds CTBP1, AS, and OTUD6B. 1 / 1
|
1
OTUD6B affects Cullin 2VHL E3 ligase complex
|
1
OTUD6B affects Carcinoma, Hepatocellular
|
1
OTUD6B inhibits Carcinoma, Hepatocellular. 1 / 1
|
1
OTUD6B affects Calpain-1 KO
|
1
Delta-actitoxin-Avd1c binds CTBP1, AS, and OTUD6B. 1 / 1
|
1
Neoplasm Metastasis affects OTUD6B
|
1
Neoplasm Metastasis inhibits OTUD6B. 1 / 1
|
1
K63 affects OTUD6B
|
1
K11- affects OTUD6B
|
1
Intellectual Disability affects OTUD6B
|
1
Intellectual Disability activates OTUD6B. 1 / 1
|
1
reach
"These results address the long‐standing questions in how far DUBs can serve as actionable therapeutic targets in cancer, particularly in patients with MM and how the UPS can contribute to the conversion of MGUS to MM.Targeting OTUD6B provides a strategy to activate let‐7 microRNAs via LIN28B destabilization to repress their targets, of which we show that MYC is the prominent determinant in MM."
Delta-actitoxin-Avd1c affects OTUD6B
|
1
Delta-actitoxin-Avd1c binds CTBP1, AS, and OTUD6B. 1 / 1
|
1
Delta-actitoxin-Avd1a affects mtf1
|
1
Delta-actitoxin-Avd1a binds OTUD6B and mtf1. 1 / 1
|
1
Calpain-1 KO mice affects OTUD6B
|
1
Delta-actitoxin-Avd1c binds CTBP1, AS, and OTUD6B. 1 / 1
|
1
reach
"Compared with hypoxia group, hypoxia + Calpain-1 knockout group not only improved the pathological changes of PAH, but also significantly reduced the protein expression of Otud6b, suggesting that Calpain-1 plays an important role in the regulation of Otud6b.Calpain is a conservative family of calcium dependent cysteine proteases that are commonly expressed in all cells [16, 17]."
AS affects Delta-actitoxin-Avd1c
|
1
Delta-actitoxin-Avd1c binds CTBP1, AS, and OTUD6B. 1 / 1
|
1